Top Injectable Manufacturer in South Sudan – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 3 days ago
- 9 min read
Last Updated: August 23, 2026
TL;DR: South Sudan regulates medicines through the South Sudan Drug and Food Control Authority (DFCA), established under the Drug and Food Control Authority Act No. 37 of 2012 within the Ministry of Health, which registers drugs, medical devices, cosmetics and foods and issues the import/export licenses every consignment needs; the 2022 Pharmaceutical Policy and Strategy, developed with WHO, is the current framework guiding sector governance. South Sudan is landlocked and is not a Hague Apostille Convention member, so Certificates of Pharmaceutical Product and GMP certificates from India require full consular legalization rather than a faster apostille, and the great majority of import cargo, including medicines, still moves via the Port of Mombasa in Kenya along the Mombasa-Kampala-Juba corridor, even as a new Djibouti-linked river and road corridor begins development. The country's disease burden is exceptionally heavy: malaria alone accounts for roughly 64% of all reported disease cases and close to 45% of inpatient deaths in recent WHO-reported surveillance, and maternal mortality stood near 692 per 100,000 live births in the latest UN interagency estimate, against a health system still substantially dependent on WHO, UNICEF, the Global Fund and international NGOs for the procurement and delivery of essential medicines. Farbe Firma, a WHO-GMP certified sterile injectable manufacturer in Gujarat, India producing 100+ injectable products under ISO Class 5 aseptic conditions and exporting to 30+ countries, supports South Sudanese importers, NGOs and institutional buyers with CTD/ACTD-ready documentation built for this landscape.
Key Takeaways
The South Sudan Drug and Food Control Authority (DFCA), created under the Drug and Food Control Authority Act No. 37 of 2012 and operating within the Ministry of Health, registers all drugs, medical devices, cosmetics and foods sold in the country and issues the import and export licenses required for every pharmaceutical consignment. The 2022 Pharmaceutical Policy and Strategy, developed by the Ministry of Health together with WHO, sets the current governance, regulation and programming framework for the sector, and Farbe Firma structures its CTD/ACTD dossiers to align with DFCA's documentation expectations.
We could not confirm a published WHO Global Benchmarking Tool maturity level for the DFCA — South Sudan is not among the African regulators that had reached Maturity Level 3 as of January 2025 (Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe) — so we state that openly rather than assume a rating. What is clear is that a large share of essential-medicine procurement in South Sudan runs through UN agencies and international NGOs rather than conventional private-sector tenders alone.
South Sudan is landlocked and is not a party to the Hague Apostille Convention, so Certificates of Pharmaceutical Product and GMP certificates from India must go through full consular/embassy legalization rather than the faster apostille route available to many other markets. Most import cargo, including medicines, travels via the Port of Mombasa in Kenya along the Mombasa-Kampala-Juba corridor; a 2025 Kenyan security levy of up to $5,000 per container bound for Juba (versus roughly $1,500 to Uganda) has added cost and friction to that route, while South Sudan and Djibouti signed an August 2025 memorandum of understanding to develop an alternative river-and-road corridor via Malakal.
Malaria dominates South Sudan's disease burden, accounting for roughly 64% of all reported disease cases and close to 45% of inpatient deaths in recent years, with children under five and pregnant women affected disproportionately; maternal mortality remains among the world's highest, near 692 per 100,000 live births in the latest UN interagency estimate. The Global Fund's 2024-2026 grant cycle (US$167 million, with UNDP and UNICEF) and the government's Health Sector Transformation Project, launched in July 2024 across more than 1,150 health facilities, are now central channels for essential-medicine funding and delivery.
Introduction: Why an Injectable Manufacturer in South Sudan Must Meet Global Standards
South Sudan, the world's youngest nation since its 2011 independence, runs a pharmaceutical market that leans almost entirely on imports, and nowhere does that dependence carry more risk than in sterile injectables, where a single quality failure can be fatal in a health system that already has very little margin for error. Decades of conflict, displacement and underinvestment have left much of the country's health infrastructure fragile, so hospitals, NGO clinics and the humanitarian organizations that keep large parts of the system running need documented proof of manufacturing quality, not just a competitive price sheet, before they will commit to a supplier. That is precisely the standard Farbe Firma Pvt Ltd was built around.
Operating from Gujarat, India — one of the country's major hubs for WHO-GMP certified generic and sterile injectable manufacturing — Farbe Firma produces more than 100 injectable formulations inside ISO Class 5 aseptic filling suites and already exports to more than 30 countries under CTD and ACTD dossier formats. Becoming a dependable injectable manufacturer in South Sudan means more than passing a paper audit: it means understanding that the country is landlocked, outside the Hague Apostille Convention, and that a meaningful share of purchasing decisions run through UN agencies, the Global Fund and international NGOs rather than a single centralized tender board. Farbe Firma approaches South Sudan with that full picture in view, pairing WHO-GMP-backed documentation with realistic logistics and procurement-channel planning.
What Sets a World-Class Injectable Manufacturer in South Sudan Apart
Any credible injectable manufacturer in South Sudan has to start from the South Sudan Drug and Food Control Authority (DFCA), established under the Drug and Food Control Authority Act No. 37 of 2012 within the Ministry of Health. The DFCA's board is responsible for registering drugs, poisons, chemicals, cosmetics, medical devices and foods, and for issuing the import and export licenses that every pharmaceutical consignment requires; applicants must submit documentation on product composition and country of origin as part of that process. The 2022 Pharmaceutical Policy and Strategy, developed by the Ministry of Health in collaboration with WHO, provides the overarching framework for governance, regulation and programming across the sector, and Farbe Firma builds its technical files in CTD/ACTD format to map cleanly onto what DFCA reviewers expect to see.
We have not been able to confirm a current, published WHO Global Benchmarking Tool maturity classification for the DFCA, and South Sudan is not among the handful of African regulators — Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe as of January 2025 — that have reached Maturity Level 3, so we say that plainly rather than guess at a rating. What is worth being direct about is that South Sudan's medicine supply runs on a somewhat different model than many countries in this series: with the health system still substantially supported by WHO, UNICEF, the Global Fund and international NGOs such as Doctors Without Borders, a significant share of essential-medicine procurement flows through donor-funded and UN-coordinated channels alongside conventional private-sector importation, and Farbe Firma structures its documentation to be usable in both contexts.
Quality Systems Behind Every Batch We Ship to South Sudan
Every batch leaving Farbe Firma's Gujarat facility for South Sudan passes through the same analytical panel we apply everywhere. Identity, assay and related-substance profiling run on validated HPLC and GC methods benchmarked against USP, BP, IP and EP monographs, Karl Fischer titration confirms residual moisture in lyophilized and powder-fill products, and every sterile lot undergoes sterility testing plus bacterial endotoxin testing by the LAL method, alongside sub-visible particulate counts, pH, osmolality and fill-volume verification. This is the same certificate-of-analysis and validation package that DFCA reviewers, and any UN agency or NGO running its own technical pre-qualification, will expect to see referenced in the registration or tender file.
Stability data is generated under ICH Q1A(R2) long-term and accelerated conditions, with photostability assessed per ICH Q1B, so shelf-life claims hold up under South Sudan's climate and the realities of the journey from Gujarat. Nearly all cargo, including medicines, still moves via the Port of Mombasa in Kenya and then overland along the Mombasa-Kampala-Juba corridor — a route that in 2025 has faced new friction from a Kenyan security levy of up to $5,000 per container destined for Juba, on top of ordinary seasonal road conditions and border delays. A river-and-road corridor via Djibouti and Malakal, agreed in principle in August 2025, may eventually offer an alternative, but for now we plan shipments and cold-chain packaging around the established Mombasa route rather than assuming a faster option is already operational.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in South Sudan for Global Buyers
South Sudan's disease burden gives injectable demand a clear shape. Malaria accounts for roughly 64% of all reported disease cases and close to 45% of inpatient deaths in recent years, with the highest-burden states — Western Bahr el Ghazal, Northern Bahr el Ghazal and Warrap — running well above the national average, and children under five and pregnant women bearing a disproportionate share of severe cases; injectable artesunate and other antimalarials are consequently in constant demand. Maternal mortality remains among the highest in the world, near 692 per 100,000 live births in the latest UN interagency estimate, keeping oxytocics, magnesium sulfate and injectable antibiotics essential in delivery rooms that are frequently under-resourced, while recurring displacement and flooding sustain steady need for IV fluids and broad-spectrum injectable antibiotics.
For distributors, NGOs and institutional buyers who need more than a standard catalogue, Farbe Firma also operates as a CDMO/CMO partner, building private-label sterile injectables on the same WHO-GMP, ISO Class 5 platform, with technical files organized in CTD/ACTD format so they can support both DFCA registration and the technical documentation UN agencies and NGOs typically require before including a supplier in a quotation or framework agreement. UNICEF's role in integrated pharmaceutical procurement, quantification and forecasting for the country, alongside the Global Fund's 2024-2026 grant cycle and the government-led Health Sector Transformation Project launched in July 2024, are all relevant channels a registered, WHO-GMP-backed manufacturer should be prepared to support alongside conventional commercial import routes.
In practice, a South Sudan launch timeline is shaped less by manufacturing capability than by two things: the legalization chain for Certificates of Pharmaceutical Product and GMP certificates, which takes longer without Hague Apostille membership, and realistic planning around the Mombasa-Kampala-Juba corridor's cost and congestion, particularly since the 2025 Kenyan security levy on Juba-bound containers. We recommend starting the DFCA registration file and the consular legalization process in parallel with partner selection, and building buffer time into shipping schedules rather than assuming best-case transit — a posture that matters even more in a market where large parts of the health system depend on donor and NGO coordination rather than routine commercial timelines.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer for South Sudan?
Yes. Farbe Firma is a WHO-GMP certified sterile injectable manufacturer based in Gujarat, India, operating ISO Class 5 aseptic filling lines and producing more than 100 injectable products for export to over 30 countries. Our technical documentation is organized in CTD and ACTD formats so it can be adapted both to the South Sudan Drug and Food Control Authority's registration requirements and to the technical files UN agencies and NGOs often require before including a supplier in procurement.
How does injectable product registration actually work in South Sudan?
Registration runs through the South Sudan Drug and Food Control Authority (DFCA), established under the Drug and Food Control Authority Act No. 37 of 2012 within the Ministry of Health. Applicants submit documentation on product composition and country of origin, and the DFCA's board reviews and registers the product while also issuing the import/export license needed to move it into the country. The 2022 Pharmaceutical Policy and Strategy, developed with WHO, provides the broader governance framework the DFCA operates within.
Do we need a local partner or agent to sell injectables in South Sudan?
A locally engaged partner or agent is strongly advisable given the DFCA's documentation requirements and the country's logistics realities. Because a substantial share of essential-medicine procurement in South Sudan also runs through UN agencies, the Global Fund and international NGOs rather than conventional commercial tenders alone, manufacturers should be prepared to work through both a commercial in-country partner and, where relevant, donor-coordinated procurement channels.
Which injectables are in strongest demand in South Sudan?
Given the country's disease burden, injectable antimalarials such as artesunate see constant demand due to malaria's outsized share of disease cases and inpatient deaths, alongside oxytocics, magnesium sulfate and injectable antibiotics for maternal health, IV fluids for displacement- and flood-related needs, and broad-spectrum antibiotics generally. Farbe Firma's 100+ product range covers all of these categories.
What documentation and logistics considerations matter most for a South Sudan launch?
Because South Sudan is not a Hague Apostille Convention member, Certificates of Pharmaceutical Product and GMP certificates from India require full consular/embassy legalization, which takes longer than an apostille — plan accordingly. On logistics, most cargo still moves via the Port of Mombasa and the Mombasa-Kampala-Juba corridor, a route affected in 2025 by a new Kenyan security levy on Juba-bound containers, so buffer time and cost should be built into shipping plans rather than assumed away.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments